For instance, in a preclinical study targeting IL13Rα2-positive gliomas, the expression of IL-15 significantly extended the survival of IL13Rα2-CAR T cells and improved their efficacy against gliomas. The gene discussed is IL13RA2; the disease is central nervous system cancer.